The impact of concomitant hepatitis C virus infection on liver and cardiovascular risks in patients with metabolic-associated fatty liver disease
Journal
European journal of gastroenterology & hepatology
Journal Volume
35
Journal Issue
11
Date Issued
2023-11-01
Author(s)
Abstract
Chronic hepatitis C virus (HCV)-infected patients with hepatic steatosis are excluded from the diagnosis of nonalcoholic fatty liver disease (NAFLD). The new name and diagnostic criteria of metabolic-associated fatty liver disease (MAFLD) were proposed in 2020 to replace the original term NAFLD. The clinical outcome of MAFLD patients with concomitant chronic HCV infection requires further investigation.
Subjects
atherosclerosis | carotid plaque | fatty liver index | fibrosis-4 index | hepatic C virus | hepatic steatosis | intima-media thickness | liver fibrosis | metabolic-associated fatty liver disease | nonalcoholic fatty liver disease fibrosis score | nonalcoholic liver disease
Type
journal article